EGFR and colorectal carcinoma: Chemotherapy for CRC has improved substantially over the last decade with the development of new cytotoxic drugs and molecular targeted agents, including anti-epidermal growth factor receptor (EGFR) antibody and anti-vascular endothelial growth factor (VEGF) antibody.